The phrase "literally stops tumors in their tracks" refers to an experimental "super vaccine" developed by researchers at the University of Massachusetts Amherst that has shown remarkable success in preventing cancer growth and spread in mice. The study was published in the journal Cell Reports Medicine in October 2025.
Key Details
- Mechanism: The nanoparticle-based vaccine uses a lipid nanoparticle "super adjuvant" to trigger a powerful, multi-pathway immune response and create long-lasting immune memory.
- Effectiveness in Mice: In preclinical trials, the vaccine prevented melanoma, pancreatic, and triple-negative breast cancers, with up to 88% of mice remaining tumor-free.
- Function: Unlike traditional cancer therapies that aim to shrink existing tumors, this new vaccine is designed to stop tumors from forming or spreading at all by training the immune system to recognize and destroy cancer cells early.
- Adaptability: The platform is adaptable and could potentially be tailored for high-risk individuals or used for universal cancer prevention. The researchers even tested a version using killed tumor cells, showing similar strong protection across multiple cancer types.
- Current Status: The vaccine is currently in early startup and translational stages and is being advanced toward human testing.
No comments:
Post a Comment